EUVIMEDEUVIMED entdecken
Open Access

RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signaling

Zhenfang Du, Lili Li, Xingsheng Shu, Chen Li, Qian Tao

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.124734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Zhenfang Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Developmental Biology, School of Medicine, Southeast University, Nanjing, Jiangsu 210003, China. Hauptthemen laut MEDLINE: Thrombospondins, Wnt Signaling Pathway. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

R-spondins are a family of four secretory proteins reported to be Wnt agonists. Among them, R-spondin 4 (RSPO4) is unique, with the lowest binding affinity towards ZNRF3/RNF43 and the lowest efficacy in regulating Wnt/β-catenin signaling. RSPO4 has been shown to play important roles in nail development, liver fibrogenesis and periodontitis, while its role in cancerous context remains largely unknown. In this study, we performed multi-omic analysis on transcriptional expression and methylation pattern of RSPO4. In vitro cell-based assays were performed to evaluate the functionality of RSPO4. Through cancer epigenomics, we identified RSPO4 as a candidate tumor suppressor with tumor-specific epigenetic inactivation. We further found that RSPO4 is readily expressed in human normal tissues, but frequently downregulated or silenced in multiple cancer types due to its promoter CpG methylation. Functional studies showed that RSPO4 inhibited tumor cell proliferation, migration, invasion and stemness, through antagonizing canonical and non-canonical Wnt signaling. Mechanistically, RSPO4 exerted suppressive effects on Wnt signaling in an LGR4/5- and ZNRF3- dependent manner, through promoting LRP6 degradation and ZNRF3 stabilization. Our study revealed a novel role of RSPO4 as a tumor suppressor through antagonizing Wnt signaling, which provides important implications for development of diagnostic biomarkers and targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombospondinsWnt Signaling PathwayHumansCell ProliferationDNA MethylationR-SpondinsCell Line, TumorCell MovementGene Expression Regulation, NeoplasticUbiquitin-Protein Ligases

Stichwörter der Autor:innen

DNA methylationRSPO4Wnt signalingmetastasisproliferationstemness

Substanzen

ThrombospondinsR-SpondinsRSPO4 protein, humanZNRF3 protein, humanUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Genetics and Developmental Biology, School of Medicine, Southeast University, Nanjing, Jiangsu 210003, China.
  • Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
  • School of Medicine, Health Science Center, Shenzhen University, Shenzhen 518060, China.

Zitieren

APA

Du, Z., Li, L., Shu, X., Li, C., & Tao, Q. (2026). RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signaling. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.124734

Vancouver

Du Z, Li L, Shu X, Li C, Tao Q. RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signaling. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.124734

BibTeX
@article{Du2026,
  author = {Du, Zhenfang and Li, Lili and Shu, Xingsheng and Li, Chen and Tao, Qian},
  title = {RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signaling},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.124734}
}
Kostenlos starten →